In conclusion, we comprehensively analyzed genetic alterations in CRC using data from both the TCGA database and a Chinese patient cohort, revealing the prominent roles of KRAS, TP53, and APC mutations in CRC pathogenesis. This evidence concerns the gene KRAS and colorectal carcinoma.